Status:

COMPLETED

Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria Infections

Lead Sponsor:

Anders Björkman

Collaborating Sponsors:

Muhimbili University of Health and Allied Sciences

Conditions:

Plasmodium Falciparum Malaria

Eligibility:

All Genders

6-59 years

Brief Summary

The aim of the study was to follow clearance of malaria infections and detection of new malaria episodes after initiation of antimalarial treatment in Tanzanian children. For this purpose the investig...

Eligibility Criteria

Inclusion

  • children between 6-59 months
  • fever (≤37.5 C) or history of fever during the preceding 24 hours
  • confirmed P.falciparum monoinfection
  • uncomplicated malaria
  • parasite density between 2000-250.000/µL
  • willing/able to comply with the 42 day follow up
  • informed concent from patient/guardian

Exclusion

  • children with history of antimalaria drug intake within the last two weeks
  • symptoms / signs of severe disease

Key Trial Info

Start Date :

June 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2012

Estimated Enrollment :

53 Patients enrolled

Trial Details

Trial ID

NCT01843764

Start Date

June 1 2009

End Date

June 1 2012

Last Update

May 3 2013

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Mlandizi Health Centre and Fukayosi dispencary

Dar es Salaam, Kibaha and Bagamoyo District, Tanzania

2

Muhimbili University of Health Allied Science

Dar es Salaam, Tanzania, 65001